Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
437.00    -9.00 (-2.02%)
Bid:
436.50
Ask:
441.50
Spread: 5.00 (1.145%)
Market Cap: £214.92m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Statement

14 Jan 2016 07:00

RNS Number : 8085L
Zotefoams PLC
14 January 2016
 

Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update

 

14 January 2016 - Zotefoams, a world leader in cellular material technology, today provides a trading update following the Company's financial year end on 31 December 2015.

 

The Board expects to report an outcome in line with management expectations for the year ended 31 December 2015. Sales1 in the second half of 2015 grew by around 13% compared to the equivalent period in 2014. This is expected to deliver sales growth of approximately 10% for the financial year as a whole.

Polyolefin sales value grew by around 7% for the year, with a 10% growth in volume offset by adverse foreign exchange rates. High-Performance Products sales grew by approximately 24%. In MuCell Extrusion LLC, our technology licensing business, we have achieved a lower average conversion cost to customers which makes adoption of the technology more attractive to customers. During the year we shipped equipment to convert 36 extrusion lines (2014: 20), increasing our overall installed base at customers by 69% to 88 units.

In Walton, Kentucky, USA, we are investing in global capacity to support future sales growth. A delay in the supply of a major piece of equipment means that the commencement of manufacturing from this investment is now expected to be approximately four months later than originally planned. We do not, however, anticipate any adverse impact on our ability to meet our growth forecast due to operational efficiency improvements achieved in Croydon, UK.

As detailed in the announcement on 24 November 2015, Gary McGrath has joined the Board as Finance Director Designate and will be formally appointed Finance Director on 1 February 2016. Clifford Hurst will work with Gary to complete the handover of this role, retiring from the Board and the Company in advance of the AGM in May 2016, as previously stated.

The Board expects to announce preliminary results for the year ended 31 December 2015 on Tuesday 15 March, 2016.

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0203-727-1000

Victoria Foster Mitchell

Simon Conway

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

ZOTEK® is a registered trademark of Zotefoams plc. MuCell® is a registered trademark of Trexel Inc. T-Tubes® is a registered trademark of UFP Technologies Inc.

 

 

1 Sales made by joint ventures as well as those made by Zotefoams plc and its subsidiaries.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBJMRTMBABBBF
Date   Source Headline
14th May 20203:15 pmRNSDirector/PDMR Shareholding
6th May 20207:00 amRNS2019 Annual Report and Notice of the 2020 AGM
28th Apr 20204:39 pmRNSDisclosure of rights attached to equity shares
22nd Apr 20203:51 pmRNSDirector/PDMR Shareholding
16th Apr 202012:39 pmRNSDirector/PDMR Shareholding
14th Apr 20202:41 pmRNSDirector/PDMR Shareholding
8th Apr 20204:19 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSPreliminary Results
1st Apr 20207:00 amRNSNotice of Results
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNS2019 Summary, COVID-19 and Current Trading Update
23rd Mar 20207:00 amRNSDelayed Preliminary Results
19th Mar 20208:40 amRNSDirectorate Change
17th Mar 20209:49 amRNSHolding(s) in Company
12th Mar 20204:11 pmRNSDirector/PDMR Shareholding
10th Mar 20204:30 pmRNSNotice of Results
27th Feb 20203:00 pmRNSDirector Declaration
12th Feb 20209:24 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSYear-End Trading Update
16th Jan 20203:33 pmRNSHolding(s) in Company
13th Jan 20204:21 pmRNSDirector/PDMR Shareholding
27th Dec 20199:03 amRNSHolding(s) in Company
17th Dec 20199:34 amRNSDirector/PDMR Shareholding
13th Dec 20198:41 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSHolding(s) in Company
26th Nov 201910:39 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSDirector/PDMR Shareholding
15th Oct 20192:50 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20199:48 amRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20194:31 pmRNSHolding(s) in Company
9th Oct 20192:37 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSNew technology for recyclable packaging
8th Oct 20197:00 amRNSAppointment of Joint Broker
3rd Oct 20197:00 amRNSTrading Update
1st Oct 201911:47 amRNSDirector Declaration
16th Sep 20193:39 pmRNSDirector/PDMR Shareholding
6th Sep 201912:07 pmRNSSecond Price Monitoring Extn
6th Sep 201912:02 pmRNSPrice Monitoring Extension
27th Aug 201912:07 pmRNSSecond Price Monitoring Extn
27th Aug 201912:02 pmRNSPrice Monitoring Extension
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn
21st Aug 201912:02 pmRNSPrice Monitoring Extension
13th Aug 20193:26 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results
15th Jul 20194:31 pmRNSDirector/PDMR Shareholding
12th Jul 20193:51 pmRNSDirector/PDMR Shareholding
10th Jul 20194:22 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.